Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
about
Endothelial nitric oxide synthase: a potential therapeutic target for cerebrovascular diseasesNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceNitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malariaMethylglyoxal modulates endothelial nitric oxide synthase-associated functions in EA.hy926 endothelial cellsMolecular architecture of mammalian nitric oxide synthases.In Vivo Inhibition of miR-155 Promotes Recovery after Experimental Mouse StrokeIntensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke.Mechanism of endothelial nitric oxide synthase phosphorylation and activation by tentacle extract from the jellyfish Cyanea capillata.Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury.Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury.Silencing a Multifunctional microRNA Is Beneficial for Stroke Recovery.The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
P2860
Q26752894-83A332C5-1151-4A24-A1E0-015D9936FFFCQ26999061-AF617872-CF2E-4BF7-AD59-D7D8EA5B2A93Q27334444-4ACA656C-FF9D-4078-9632-00A9F4065DFBQ33589250-E670E095-7494-4DC1-A119-9C6C13B26E85Q34144575-CF2DF477-47EF-46F7-9CD7-3BCCA70942C2Q36038242-952222A6-7007-4B37-9734-F1B480AD8254Q36251159-4CBDF721-758D-4BA9-8E9C-B51EC6EE8019Q38649591-7B3825D7-F3B0-46C5-8615-E7644679D3F8Q39324614-29F6231D-DF71-43E9-B4F8-3BE41E47756AQ42041503-F4268193-1D47-4F9B-A510-EE1B1EF0F574Q47158221-9500D4E1-2587-41B8-925D-E8B4FEA399DDQ48284118-78AE2835-46AF-4B88-BE2D-644BE8403563Q52661746-9E9FD901-1347-44F5-87BA-3E10AE8E2339Q55163277-047029FF-F1EA-43AD-BA02-43A2E73BA920
P2860
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@en
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@nl
type
label
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@en
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@nl
prefLabel
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@en
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@nl
P2093
P2860
P1476
Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.
@en
P2093
Kirtiman Srivastava
Philip M W Bath
Ulvi Bayraktutan
P2860
P2888
P304
P356
10.1007/S10571-011-9777-Z
P577
2011-12-25T00:00:00Z